Sofosbuvir-Velpatasvir-Voxilaprevir in Adolescents 12 to 17 Years Old With Hepatitis C Virus Infection.
Sign Up to like & getrecommendations! Published in 2022 at "Hepatology"
DOI: 10.1002/hep.32393
Abstract: BACKGROUND & AIMS Sofosbuvir-velpatasvir-voxilaprevir is a pangenotypic regimen for chronic hepatitis C virus (HCV) infection. In the United States and Europe, sofosbuvir-velpatasvir-voxilaprevir once daily for 12 weeks is indicated for adults previously receiving an HCV… read more here.
Keywords: infection; velpatasvir voxilaprevir; sofosbuvir velpatasvir; hepatitis virus ... See more keywords
Effectiveness and safety of Sofosbuvir/Velpatasvir/Voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: a real-life study from the Navigatore Lombardia and Veneto Networks
Sign Up to like & getrecommendations! Published in 2019 at "Digestive and Liver Disease"
DOI: 10.1016/j.dld.2018.11.063
Abstract: Division of Gastroenterology and Hepatology, IRCCS Ospedale Maggiore Policlinico, Milan, Italy [email protected] E. Degasperi1, A. Spinetti2, A. Lombardi3, S. Landonio4, P. G. Scotton5, L. Pasulo6, P. Pozzoni7, A. Giorgini8, P. Fabris9, A. Romano10, L. Lomonaco11,… read more here.
Keywords: effectiveness safety; sofosbuvir velpatasvir; retreatment chronic; voxilaprevir retreatment ... See more keywords
Sofosbuvir + velpatasvir + voxilaprevir for the treatment of hepatitis C infection
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2018.1459567
Abstract: ABSTRACT Introduction: Hepatitis C is a disease with a significant global impact. Over the last several years, the treatment of the disease has been revolutionized. Therapy has transformed over the last several years with the… read more here.
Keywords: sofosbuvir velpatasvir; hepatitis; treatment; treatment hepatitis ... See more keywords
Safety and efficacy of sofosbuvir-velpatasvir: A meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000031183
Abstract: Introduction: The sofosbuvir-velpatasvir single-tablet regimen (Epclusa) is a newly FDA-approved inhibitor of hepatitis C virus (HCV). This meta-analysis aimed to investigate the safety and efficacy of velpatasvir-sofosbuvir in the treatment of chronic HCV infection. Methods:… read more here.
Keywords: meta; sofosbuvir velpatasvir; meta analysis; safety efficacy ... See more keywords
Eczematous Drug Eruption Induced by Sofosbuvir/Velpatasvir: The Need for a Better Classification.
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000001071
Abstract: To the Editor: Second-generation direct-acting drugs (DAAs) have revolutionized the treatment of chronic hepatitis C. However, skin-related adverse effects (AEs) have not been properly described and result a common enigma for medical personnel. This is… read more here.
Keywords: sofosbuvir velpatasvir; drug; drug eruption; aes ... See more keywords
A combination of hepatic encephalopathy and body mass index was associated with the point of no return for improving liver functional reserve after sofosbuvir/velpatasvir treatment in patients with hepatitis C virus‐related decompensated cirrhosis
Sign Up to like & getrecommendations! Published in 2022 at "Hepatology Research"
DOI: 10.1111/hepr.13837
Abstract: The real‐world efficacy of sofosbuvir/velpatasvir treatment for patients with hepatitis C virus‐related decompensated cirrhosis is unclear. We aimed to identify factors that improve liver functional reserve after treatment. read more here.
Keywords: velpatasvir treatment; treatment patients; patients hepatitis; hepatitis virus ... See more keywords
Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis
Sign Up to like & getrecommendations! Published in 2022 at "Hepatology Research"
DOI: 10.1111/hepr.13868
Abstract: To determine the impact of direct‐acting antiviral therapy on the long‐term prognosis of decompensated cirrhotic patients. read more here.
Keywords: therapy clinical; therapy; clinical outcome; effect sofosbuvir ... See more keywords
Sofosbuvir/Velpatasvir Prophylaxis for 12 Weeks in Hepatitis C Virus (HCV)-Negative Recipients Receiving Kidney Transplantation from HCV-Positive Donors
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Transplantation"
DOI: 10.12659/aot.933313
Abstract: Background The aim of this study was to evaluate the efficacy and safety of Sofosbuvir/Velpatasvir prophylaxis in hepatitis C virus (HCV)-negative recipients who received a transplant kidney from HCV-infected donors. Material/Methods This retrospective cohort study… read more here.
Keywords: hcv negative; sofosbuvir velpatasvir; negative recipients; transplantation ... See more keywords
Eight versus twelve weeks of sofosbuvir-velpatasvir in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus infection: Study protocol for a multicentric, open labelled, randomized, non-inferiority trial (RESOLVE trial)
Sign Up to like & getrecommendations! Published in 2023 at "PLOS ONE"
DOI: 10.1371/journal.pone.0285725
Abstract: Background Hepatitis C virus (HCV) is a common cause of liver cirrhosis and hepatocellular carcinoma. Globally, nearly 71 million people have chronic HCV infection, and approximately 399,000 dies annually. In patients without cirrhosis, HCV infection… read more here.
Keywords: non cirrhotic; infection; trial; weeks sofosbuvir ... See more keywords
Effectiveness and Safety of Sofosbuvir-Velpatasvir in Patients with Cirrhosis Associated with Genotype 3 Hepatitis C Infection in Xinjiang, China
Sign Up to like & getrecommendations! Published in 2022 at "Infection and Drug Resistance"
DOI: 10.2147/idr.s385071
Abstract: Purpose Patients with cirrhosis from genotype 3 (GT3) hepatitis C virus (HCV) infection are difficult to cure. This study investigated the effectiveness and safety of sofosbuvir-velpatasvir (SOF/VEL) with and without ribavirin (RBV) in patients with… read more here.
Keywords: safety sofosbuvir; infection; patients cirrhosis; effectiveness safety ... See more keywords